Fig. 1From: Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug deliveryFatty acids-based prodrugs of A SN38, B cabazitaxel, C cisplatin, D gemcitabine, E mycophenolate mofetil and F dexamethasoneBack to article page